Cargando…

A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer

BACKGROUND: Lung cancer is the leading cause of cancer mortality in Canada, yet patients are often under-supported. A six-week program called Inspire Now, created to address unmet supportive care needs, was evaluated in this study. Feasibility and preliminary outcomes were assessed in order to infor...

Descripción completa

Detalles Bibliográficos
Autores principales: Conte, Ellen, Legacy, Mark, Psihogios, Athanasios, Pitman, Anne, Redway, Andrea, Hamer-Wilson, Jill, Seely, Dugald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768835/
https://www.ncbi.nlm.nih.gov/pubmed/33356632
http://dx.doi.org/10.1177/1534735420983472
_version_ 1783629218759835648
author Conte, Ellen
Legacy, Mark
Psihogios, Athanasios
Pitman, Anne
Redway, Andrea
Hamer-Wilson, Jill
Seely, Dugald
author_facet Conte, Ellen
Legacy, Mark
Psihogios, Athanasios
Pitman, Anne
Redway, Andrea
Hamer-Wilson, Jill
Seely, Dugald
author_sort Conte, Ellen
collection PubMed
description BACKGROUND: Lung cancer is the leading cause of cancer mortality in Canada, yet patients are often under-supported. A six-week program called Inspire Now, created to address unmet supportive care needs, was evaluated in this study. Feasibility and preliminary outcomes were assessed in order to inform future changes to the program. OBJECTIVES: (1) Assess the feasibility of the program and its evaluation; (2) pilot the collection of patient-reported outcomes; (3) identify outcomes that may be positively influenced; and (4) inform program modifications. METHODS: Participants were recruited from the first session of Inspire Now for an observational pilot study. The primary outcome was feasibility. Secondary outcomes included within-person changes in Functional Assessment of Cancer Therapy – Lung (FACT-L) and Measure Yourself Concerns and Wellbeing (MYCaW), and program satisfaction and qualitative experiences of participants and facilitators through internally-developed questionnaires and semi-structured interviews. Analysis was primarily descriptive, within person changes in FACT-L and MYCaW were analyzed using the Wilcoxon signed-rank test and qualitative data was assessed for common themes. RESULTS: The program and its evaluation were feasible; 8 of 9 (89%) participants consented to the study, median attendance was 6 of 6 sessions (IQR 4.5-6), and questionnaire completion was 100% at baseline and 75% at follow-up. There were clinically meaningful improvements in MYCaW concern 1 (−1.2, 95% CI −2.0 to −0.4) and overall wellbeing (−0.9, 95% CI −2.1 to 0.4). Seven of eight FACT-L sub-sections trended toward improvement, with absolute changes ranging from −1.7 to 10.8%. Participant feedback was overwhelmingly positive; group support and social interactions were highly valued. CONCLUSIONS: The group intervention for people with lung cancer was feasible to both run and evaluate. Participants responded positively to the program. Findings will inform changes to future sessions and an analysis of multiple sessions is planned.
format Online
Article
Text
id pubmed-7768835
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-77688352021-01-21 A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer Conte, Ellen Legacy, Mark Psihogios, Athanasios Pitman, Anne Redway, Andrea Hamer-Wilson, Jill Seely, Dugald Integr Cancer Ther 20 Years of Integrative Cancer Therapies BACKGROUND: Lung cancer is the leading cause of cancer mortality in Canada, yet patients are often under-supported. A six-week program called Inspire Now, created to address unmet supportive care needs, was evaluated in this study. Feasibility and preliminary outcomes were assessed in order to inform future changes to the program. OBJECTIVES: (1) Assess the feasibility of the program and its evaluation; (2) pilot the collection of patient-reported outcomes; (3) identify outcomes that may be positively influenced; and (4) inform program modifications. METHODS: Participants were recruited from the first session of Inspire Now for an observational pilot study. The primary outcome was feasibility. Secondary outcomes included within-person changes in Functional Assessment of Cancer Therapy – Lung (FACT-L) and Measure Yourself Concerns and Wellbeing (MYCaW), and program satisfaction and qualitative experiences of participants and facilitators through internally-developed questionnaires and semi-structured interviews. Analysis was primarily descriptive, within person changes in FACT-L and MYCaW were analyzed using the Wilcoxon signed-rank test and qualitative data was assessed for common themes. RESULTS: The program and its evaluation were feasible; 8 of 9 (89%) participants consented to the study, median attendance was 6 of 6 sessions (IQR 4.5-6), and questionnaire completion was 100% at baseline and 75% at follow-up. There were clinically meaningful improvements in MYCaW concern 1 (−1.2, 95% CI −2.0 to −0.4) and overall wellbeing (−0.9, 95% CI −2.1 to 0.4). Seven of eight FACT-L sub-sections trended toward improvement, with absolute changes ranging from −1.7 to 10.8%. Participant feedback was overwhelmingly positive; group support and social interactions were highly valued. CONCLUSIONS: The group intervention for people with lung cancer was feasible to both run and evaluate. Participants responded positively to the program. Findings will inform changes to future sessions and an analysis of multiple sessions is planned. SAGE Publications 2020-12-24 /pmc/articles/PMC7768835/ /pubmed/33356632 http://dx.doi.org/10.1177/1534735420983472 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle 20 Years of Integrative Cancer Therapies
Conte, Ellen
Legacy, Mark
Psihogios, Athanasios
Pitman, Anne
Redway, Andrea
Hamer-Wilson, Jill
Seely, Dugald
A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer
title A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer
title_full A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer
title_fullStr A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer
title_full_unstemmed A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer
title_short A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer
title_sort prospective outcomes pilot evaluation of inspire now: a program for people with lung cancer
topic 20 Years of Integrative Cancer Therapies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768835/
https://www.ncbi.nlm.nih.gov/pubmed/33356632
http://dx.doi.org/10.1177/1534735420983472
work_keys_str_mv AT conteellen aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT legacymark aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT psihogiosathanasios aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT pitmananne aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT redwayandrea aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT hamerwilsonjill aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT seelydugald aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT conteellen prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT legacymark prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT psihogiosathanasios prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT pitmananne prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT redwayandrea prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT hamerwilsonjill prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer
AT seelydugald prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer